Associate Professor Masaru Hatano
University of Tokyo Hospital, Tokyo (Japan)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Identification of predictors of response to initial oral combination therapy in WHO-functional class II or III PAH patients: A post-hoc analysis of the AMBITION study
Event: ESC Congress 2020
Topic: Pulmonary Hypertension
Session: Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure ePosters
ESC 365 is supported by
